Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes... Show more
A.I.dvisor indicates that over the last year, PHR has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PHR jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To PHR | 1D Price Change % | ||
|---|---|---|---|---|
| PHR | 100% | +3.11% | ||
| COIN - PHR | 57% Loosely correlated | -2.72% | ||
| CLSK - PHR | 55% Loosely correlated | +0.71% | ||
| QTWO - PHR | 49% Loosely correlated | +0.47% | ||
| QLYS - PHR | 49% Loosely correlated | +4.99% | ||
| RIOT - PHR | 49% Loosely correlated | +1.82% | ||
More | ||||
| Ticker / NAME | Correlation To PHR | 1D Price Change % |
|---|---|---|
| PHR | 100% | +3.11% |
| Health Services category (240 stocks) | 40% Loosely correlated | +1.85% |
| Services to the Health Industry category (42 stocks) | 13% Poorly correlated | +2.23% |
a provider of patient check-in solutions for medical practices
Industry ServicestotheHealthIndustry
PHR moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend. In 35 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PHR's RSI Oscillator exited the oversold zone, 22 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on September 30, 2026. You may want to consider a long position or call options on PHR as a result. In 59 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for PHR just turned positive on September 30, 2026. Looking at past instances where PHR's MACD turned positive, the stock continued to rise in 37 of 53 cases over the following month. The odds of a continued upward trend are 70%.
Following a +1.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHR advanced for three days, in 218 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
PHR broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PHR entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. PHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.883) is normal, around the industry mean (3.883). PHR has a moderately high P/E Ratio (62.667) as compared to the industry average of (12.839). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (1.270) is also within normal values, averaging (6.065).
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.